Prominent Plant-Based Vaccines Market Trend for 2025: Key Players Pioneering Plant-Based COVID-19 Vaccine Innovation To Sustain Their Position In The Market

Which drivers are expected to have the greatest impact on the over the plant-based vaccines market's growth?
The increase of infectious illnesses is predicted to drive the expansion of the plant-based vaccine market in the future. Diseases caused by microorganisms such as bacteria, viruses, fungi, or parasites are known as infectious diseases. Plant-based vaccines, used in both traditional and modern medicine, can provide safe, effective, and stable prophylactics, vaccines, and treatments that are reasonably priced to deal with a variety of health conditions, which include infectious diseases. As an illustration, the Global Tuberculosis Report released by the World Health Organization, a Switzerland-based international health organization, disclosed in October 2022 that the worldwide occurrence of TB was at approximately 10.6 million cases at a rate of 134 cases for every 100,000 individuals. The Southeast Asia region was responsible for 45% of the reported TB cases, followed by Africa, which had 23% of all cases. As a result, the broad occurrence of infectious illnesses is spurring the expansion of the plant-based vaccine market.

Get Your Plant-Based Vaccines Market Report Here:
https://www.thebusinessresearchcompany.com/report/plant-based-vaccines-global-market-report

What is the future CAGR of the plant-based vaccines market, and how will it impact industry expansion?
The market size for plant-based vaccines has witnessed significant expansion in the past few years. The value is projected to rise from $1.66 billion in 2024 to about $1.83 billion in 2025, with an annual growth rate of 10.2%. The growth observed in the historic period is primarily due to factors such as the challenges being faced in the traditional vaccine production, the need for producing vaccines at lower costs, the advent of plant molecular farming, lessened potential for allergies, and the application of synthetic biology.

Anticipated to witness substantial expansion in the imminent years, the market size of plant-based vaccines is projected to reach $2.79 billion by 2029, ensuring a compound annual growth rate (CAGR) of 11.1%. The upsurge during the forecasted time frame can be ascribed to preparation for pandemics, worldwide health safeguards, enlargement of vaccine utilization, and the embracing of this method by the pharmaceutical industry. In the same time period, significant trends will encompass advancements in plant biotechnology, sustainable environment, AI incorporation, and the amalgamation of Machine Learning.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12144&type=smp

How are the latest trends influencing the growth of the plant-based vaccines market?
One of the key trending areas in the plant-based vaccine industry is product innovation. To maintain their competitive edge, prominent companies in the market are focusing their efforts on creating original products. As an example, in February 2022, Medicago Inc. from Canada and GSK PLC based in the UK made an announcement that Health Canada had given their approval for COVIFENZ, a COVID-19 vaccine. This vaccine, COVIFENZ, is notable because it's the first adjuvanted, recombinant plant-based virus-like particles [VLP] SARS-CoV-2 vaccine. It uses CoVLP (COVID-19-like particle) technology and contains recombinant spike (S) glycoproteins that are formed as virus-like particles (VLPs).

Which key market segments comprise the plant-based vaccines market and drive its revenue growth?
The plant-based vaccines market covered in this report is segmented -

1) By Vaccine Type: Bacterial Vaccines, Viral Vaccines, Parasite Vaccines, Other Vaccine Types
2) By Source: Tobacco Plant, Maize, Potato, Other Sources
3) By Application: Influenza, Zika Virus, Ebola Virus, Poultry Disease, Other Applications

Subsegments:
1) By Bacterial Vaccines: Recombinant Bacterial Vaccines, Conjugate Bacterial Vaccines, DNA-Based Bacterial Vaccines
2) By Viral Vaccines: Inactivated Viral Vaccines, Live Attenuated Viral Vaccines, Subunit Viral Vaccines
3) By Parasite Vaccines: Recombinant Parasite Vaccines, DNA-Based Parasite Vaccines
4) By Other Vaccine Types: Fungal Vaccines, Multivalent Vaccines, Toxin-Based Vaccines

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12144

What regions are at the forefront of plant-based vaccines market expansion?
North America was the largest region in the plant-based vaccines market in 2024. The regions covered in the plant-based vaccines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Who are the leading players fueling growth in the plant-based vaccines market?
Major companies operating in the plant-based vaccines market include Sanofi Pasteur SA, GlaxoSmithKline plc., British American Tobacco PLC, ICON Plc., Agenus Inc., Medicago Inc., Panacea Biotec Limited, Creative Biolabs Inc., InVitria, Fraunhofer USA Inc., Biodextris Inc., Intravacc B.V, Avesthagen Limited, Calyxt Inc., Zyus Life Sciences Inc., Mapp Biopharmaceutical Inc., Kentucky BioProcessing Inc., Planet Biotechnology Inc., Icon Genetics GmbH, PlantForm Corporation, LenioBio GmbH, iBio Inc., Lumen Bioscience Inc., Baiya Phytopharm Co. Ltd., Greenovation Biotech GmbH, Pevion Biotech AG

Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/sample.aspx?id=12144&type=smp

What Is Covered In The Plant-Based Vaccines Global Market Report?

• Market Size Forecast: Examine the plant-based vaccines market size across key regions, countries, product categories, and applications.
• Segmentation Insights: Identify and classify subsegments within the plant-based vaccines market for a structured understanding.
• Key Players Overview: Analyze major players in the plant-based vaccines market, including their market value, share, and competitive positioning.
• Growth Trends Exploration: Assess individual growth patterns and future opportunities in the plant-based vaccines market.
• Segment Contributions: Evaluate how different segments drive overall growth in the plant-based vaccines market.
• Growth Factors: Highlight key drivers and opportunities influencing the expansion of the plant-based vaccines market.
• Industry Challenges: Identify potential risks and obstacles affecting the plant-based vaccines market.
• Competitive Landscape: Review strategic developments in the plant-based vaccines market, including expansions, agreements, and new product launches.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.